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Abstract
This article examines the relationships between allergic rhinitis and hypertension, chronic
sinusitis and hypertension, and asthma and hypertension. Previous studies have demon-
strated that men reporting seasonal or chronic rhinitis had on average a 3.5 mm Hg higher
systolic blood pressure than those without allergic rhinitis. Proposed mechanisms to the rela-
tionship between allergic rhinitis and sinusitis with hypertension may lie in the pathway of
obstructive sleep apnea via neurohumoral responses to hypoxemia. Asthmatics were 1.4 times
more likely to have heart disease, and 1.3 times more likely to have high blood pressure, than
non-asthmatics. The commonality of immunological dysfunction and inflammation between
diseases of allergy and those mediated by hypertension and other vascular disorders may
explain the correlations observed. Interestingly, obese individuals have higher levels of circulating
IL-6, leptin and TNF-alpha skewing the immune system toward the allergen-reactive type 2
helper T-cell. This would mean that obese individuals were predisposed to diseases of chronic
inflammation. The implications of allergic rhinitis, chronic sinusitis, and asthma deserve
closer attention, especially into the possibility of co-morbidity for hypertension. Although asso-
ciations between allergic diseases and hypertension have been reported, more studies need to be
performed to elucidate the mechanisms behind such associations. (Cardiol J 2010; 17, 5: 443–447)
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Introduction
Population studies have demonstrated that the
prevalence of hypertension and allergic diseases
both continue to increase year on year. The con-
current rise in both diseases raises the question of
whether there is a relationship between atopic dis-
ease and hypertension. The Hagerstown study was
originally designed to determine whether urban re-
sidence affected respiratory function in non-smok-
ers. The results of the study showed that among
the 270 non-smokers, respiratory allergies were
associated with a three-fold increased risk of hyper-
tension [1]. In a different study, Stebbings [1] re-
viewed the relationship between allergic disease
and hypertension among New York City transit
workers, demonstrating that transit workers with
asthma and hay fever had higher systolic blood pres-
sures (SBP) and were prescribed more anti-hyper-
tensives than their non-asthmatic, non-allergenic
colleagues [1]. The authors concluded that respira-
tory allergies may be risk factors for hypertension.
This article will review the existing studies
correlating allergic disease and hypertension, the
putative mechanisms of such an association, and the
clinical implications of such a relationship.
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Allergic rhinitis and hypertension
Kony et al. [2] examined whether there was
a relationship between allergic rhinitis and elevated
arterial blood pressure (BP). The study population
consisted of 316 subjects (146 men and 170 women)
between the ages of 22 and 44. Subjects were con-
sidered to have allergic rhinitis by self reported
questionnaire. Subjects were classified as being
hypertensive when their SBP was at least 140 mm
Hg and/or their diastolic blood pressure (DBP) was
at least 90 mm Hg, and/or they reported using an
antihypertensive treatment [2]. Treatment was also
taken into account. Eighteen of the men had used
corticosteroids in the past 12 months. In the 127 men
who had not been treated with steroids, a higher
SBP was still observed among men with allergic
rhinitis than among men without allergic rhinitis
(129.8 ± 12.8 vs 124.1 ± 12.6 mm Hg, p = 0.05).
Kony et al. [2] concluded that SBP was higher
in men with allergic rhinitis than in those without
it (130 ± 12.7  vs 123.5 ± 13.9 mm Hg, p = 0.002),
even after controlling for potential confounding fac-
tors such as age, body mass index (BMI), hyper-
cholesterolemia and smoking status. However,
there was no association between rhinitis and SBP
in women. Kony et al. [2] mentioned that a low car-
diovascular morbidity rate in premenopausal wom-
en may explain the reported association that was
restricted to men. These results were corroborat-
ed by data from the Wisconsin Sleep Cohort, which
found a significant association between seasonal and
chronic rhinitis and elevated SBP in men, after ad-
justing for age, BMI, hypercholesterolemia, smok-
ing and medications used for respiratory conditions
that have potential blood pressure-elevating effects
[3]. Men reporting seasonal or chronic rhinitis had
on average a 3.5 mm Hg higher SBP than those
without allergic rhinitis [2].
Heinrich and Doring [4], in attempting to re-
produce the results of Kony’s study, studied a large
population sample of 4,856 subjects aged 25–64.
A Hawksley Random Zero sphygmomanometer was
used in this study, as opposed to a digital electron-
ic tensiometer in Kony’s study. Three BP record-
ings were taken after the subject was at rest in
a sitting position for an average of 30 minutes. Hy-
pertension was diagnosed as SBP greater than, or
equal to, 140 or 90 mm Hg diastolic or use of anti-
hypertensive medication. Neither average SBP nor
DBP was significantly different between men with
and without allergic rhinitis [4]. There is perhaps
more operator--dependent variability in manually
measuring BP. In addition, in Heinrich’s study, par-
ticipants’ BPs were measured from a sitting position,
whereas in Kony’s study the measurement was done
in the supine position [4]. Such methodological differ-
ences could be significant, given that the increment
in SBP between men with allergic rhinitis and with-
out allergic rhinitis was approximately 7 mm Hg in
the Kony study and only 3.5 mm Hg in the Wisconsin
study [4].
An association between allergic rhinitis and
hypertension had been identified in men, but not in
women, until a recent study by Corbo et al. [5]. This
found an association between increased SBP and
allergic rhinitis in post-menopausal women. On first
thought, one may hypothesize that lower estrogen
levels, which increase the risk of hypertension,
explain the association of SBP and rhinitis as being
stronger in post-menopausal than in premenopausal
women. However, the prevalence of snoring is also
significantly higher in the post-menopausal age
group [5]. In fact, habitual snorers were older, with
a larger BMI and a larger waist-to-hip ratio than
non-snorers. Post-menopausal women with habi-
tual snoring and allergic rhinitis had the significantly
highest SBP [5]. A proposed mechanism is that
subjects with nasal congestion due to allergy or
nasal obstruction were more likely to be habitual
snorers, with frequent episodes of apnea and hypo-
pnea during sleep, triggering sympathetic drive and
ultimately leading to higher SBP [5]. Post-meno-
pausal women who snore and have allergic rhinitis
should be checked for hypertension and for the
presence of sleep-disordered breathing.
Chronic sinusitis and hypertension
In addition to allergic rhinitis, other diseases
with an allergic etiology are associated with hyper-
tension. Several studies have demonstrated an as-
sociation between sinusitis and hypertension.
Chronic sinusitis has an estimated prevalence in the
U.S. of 14% [6]. In a study by Dales et al. [6], both
men and women with chronic sinusitis were more
likely to have hypertension than those without si-
nusitis. This analysis was based on data from 52,992
Canadian subjects (25,324 males and 27,668 fe-
males) aged 20–60. The data was adjusted for age,
smoking status, alcohol consumption, regular exer-
cise and BMI. The adjusted odds ratio between
sinusitis and hypertension for females was statisti-
cally significant at 1.42 (95% CI 1.04–1.95). For
men, it did not meet statistical significance, al-
though it was increased at 1.12.
There appears to be an association between
upper respiratory disorders, such as rhinitis and
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sinusitis, and systemic arterial hypertension. This
association may be explained through the common
ground of obstructive sleep apnea. A recent randomi-
zed controlled trial demonstrated that continuous
positive airway pressure treatment lowered the BP
by approximately 3.3 mm Hg in subjects with up-
per airway disorders treated with continuous posi-
tive airway pressure (CPAP) (95% CI 1.3–5.3), as
against those that were not [7]. Interestingly, the
sinusitis-hypertension association was stronger
among women than men, perhaps because the
former have smaller sinus ostia [7]. As with obstruc-
tive sleep apnea, increases in airway resistance in-
voke a sympathoadrenal response marked by epi-
sodic hypertension [7]. In addition to anatomical ob-
struction, chronic inflammation is known to play
a role in sinusitis, and the resultant inflammatory
mediators may increase susceptibility to hyperten-
sion. For example, elevated C-reactive protein
(CRP) has been shown to increase the risk of hy-
pertension [7]. Perhaps mediators of chronic sinus
inflammation may influence endothelial function,
explaining the observed association between chro-
nic sinusitis and chronic hypertension [7].
Asthma and hypertension
Asthma is a chronic inflammatory disorder of
the airways. Similarly, it is now recognized that in-
flammation plays a significant role in the pathogen-
esis of atherothrombosis [8]. Dogra et al. [8] were
interested in quantifying the association between
cardiovascular disease (CVD) and asthma. A total of
74,342 participants with a mean age of 56.4 ± 12.5
were divided into two groups: asthmatics and non-
asthmatics. The characteristics of each group were
examined and three outcomes were used to estimate
the relationship between asthma and CVD: high BP,
heart disease and stroke. Multiple logistic regres-
sion models revealed that asthmatics were 1.4 times
more likely to have heart disease, and 1.3 times more
likely to have high BP, than non-asthmatics [8].
Similarly, Iribarren et al. [9] performed a co-
hort study among 70,047 men and 81,573 women,
18–85 years old, to determine whether a relation-
ship between asthma and coronary artery disease
(CAD) existed. The diagnosis of asthma was
through self-report and the primary endpoint was
combined non-fatal or fatal CAD. After a median
follow-up time of 27 years, and adjusting for age,
race/ethnicity, education level, smoking status, al-
cohol consumption, BMI, serum total cholesterol,
white blood cell count, hypertension, diabetes, and
history of occupational exposures, asthma was as-
sociated with a 1.22-fold (95% CI 1.14–1.31) in-
creased hazard of CAD among women [9]. This as-
sociation between asthma and CAD has been repro-
duced in four similar studies [9].
In investigating the mechanism between asth-
ma and CAD, a pro-inflammatory state is common
to both disorders. The pathogenesis of atheroscle-
rosis is one of a deregulated immune system and
increased inflammatory response. In fact, two pro-
inflammatory cytokines that are elevated in asth-
ma, interleukin-6 (IL-6) and tumour necrosis fac-
tor-alpha (TNF-alpha) are also thought to play key
roles in the pathogenesis of atherosclerosis [10].
IL-6 has been found in human atherosclerotic
plaques, triggers acute phase reactants such as
CRP, and activates platelets and mitogenic activity
for smooth muscle cells [10]. Elevated CRP levels
are associated with age, sex, African-American race,
BMI, smoking status, serum lipids, hypertension,
presence of diabetes, frequency of exercise and
cardio-respiratory fitness [11]. A recent study by
Kasayama et al. [11] showed that asthma is an in-
dependent risk factor for elevation of CRP levels.
The study further demonstrated that plasma CRP
levels fell by 30% in response to treatment with in-
haled corticosteroids. Thus, one possible mecha-
nism linking asthma to hypertension/CVD may lie
in pathways that modulate CRP. In summary, there
is an epidemiological relationship between high
CRP and incident hypertension but no proof of cause
and effect. If the inflammation is successfully treat-
ed, one would expect the CRP levels to decline.
Discussion
Among a subset of the population, there may
be a relationship between airway-related disease
and sodium serum levels. Bronchial reactivity,
measured using a histamine challenge test, was
associated with elevated 24 hour urine sodium ex-
cretion [12]. In fact, extensive study of the plasma
of individuals with allergic asthma and/or allergic
rhinitis revealed the existence of an unknown se-
rum-borne factor that leads to the accumulation of
sodium within platelets, leukocytes, and peripher-
al blood mononuclear cells [12]. Some have suggest-
ed that lysophosphatidylcholine (LPC) may be
a likely candidate. Indeed, high serum LPC levels
have been associated with increased asthma sever-
ity and increased accumulation of Na+ in peri-
pheral blood mononuclear cells and leukocytes [12].
Skoner et al. [13] proposed that a defect in Na+/K+
pump inhibition therefore leads to intracellular
sodium accumulation.
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In fact, allergic individuals have been found to
have elevated plasma ouabain and altered salt homeo-
stasis [13]. Ouabain is a cardiotonic steroid with a sim-
ilar mechanism of action as digoxin, ultimately by in-
hibiting the sodium-potassium ATPase pump. IgE
levels were highest in those whose serum contained
increased inhibitor activity, suggesting that inhibition
of Na+/K+ pump is related to the degree of atopy
[13]. Elevated cytosolic levels of sodium promote cal-
cium influx and increases contraction of airway
smooth muscle and possibly leading to hypertension.
Hypertension in allergic individuals may resolve with
a medication that targets the Na+/K+ pump (bind-
ing sites for ouabain) [13]. However, there have been
no clinical trials to test this hypothesis.
The correlation between allergic disease and
hypertension has been established in a few studies.
However, the mechanism driving this association
has yet to be well elucidated. With regards to si-
nusitis, allergic rhinitis and asthma, the answer may
lie partly in the common ground of obstructive sleep
apnea. Allergic individuals with significant nasal
congestion/obstruction were more likely to be ha-
bitual snorers with frequent episodes of apnea
and hypopnea during sleep (i.e. to have obstructive
sleep apnea), which then leads to higher SBP and
presumably, greater susceptibility to heart disease
and stroke. Clinical experience suggests that CPAP
plus good control of one’s allergies may resolve or
facilitate treatment of hypertension.
The effects of sleep-disordered breathing and
hypertension are intriguing. Neurohumoral and
hemodynamic responses to repetitive episodes of
hypoxemia and apnea may offer a pathophysiologi-
cal basis for patients with disturbed sleep (those
with rhinitis, sinusitis, or asthma) having an in-
creased risk for hypertension. The immediate re-
sponse to hypoxia and hypercapnia is via chemore-
ceptors which increases minute ventilation and
sympathetic responses, ultimately leading to vaso-
constriction and marked surges in BPs [14]. The
increases in sympathetic activity and BP during
sleep in these patients appear to carry over into the
daytime, such that patients with disturbed sleep
have an increased prevalence of hypertension and
high levels of sympathetic nerve activity [14]. Sleep
deprivation also has many metabolic consequenc-
es, mainly via cortisol activity and insulin resis-
tance, ultimately leading to an increased risk of
hypertension, diabetes, and obesity [15].
In addition, the higher prevalence of obesity
and a sedentary lifestyle in both asthmatics and
hypertensives may muddy the relationship between
the two. Obesity has been shown to induce de-
creased immune tolerance [16]. A greater body
weight increases the level of circulating IL-6, lep-
tin and TNF-alpha, skewing the immune system
toward the allergen-reactive type 2 helper T-cell
[16]. It is well established that this Th2 cytokine
profile triggers the activation and/or recruitment of
IgE antibody producing B cells, mast cells and eosi-
nophils: the triad involved in allergic inflammation
[16]. Because there is a significant increase in this
response in obese people, therefore, there is a high-
er prevalence of diseases of chronic inflammation.
These diseases include CVD, type II diabetes, stoke
and atopic diseases such as asthma and allergies.
Since allergic rhinitis appears to be a potential
co-morbidity for hypertension, the question arises
as to whether allergic rhinitis plays a role in other
vascular disorders such as myocardial infarction or
stroke. In fact, the relationship between allergic
rhinitis and stroke was recently  the subject of two
studies. In the first, by Low et al. [17], increased
hospital admission rates for stroke were positively
correlated with the presence of upper respiratory
infection, pollen allergy, and increased air pollution.
In a second study by Matheson et al. [18], a population
of 9,272 participants with an average age of 62 was
followed over 4.4 years. Patients with a history of
stroke or CAD were excluded because of their high
risk of stroke. Of the 125 participants who had had
strokes, 2.2% of those with a history of hay fever
suffered a stroke, compared to 1.25% of those with
no history of hay fever (p = 0.02) [18]. Participants
with a history of hay fever had an unadjusted haz-
ard ratio (HR) of 1.72 (95% CI 1.08–2.27) for stroke
versus participants without hay fever. Risk of stroke
remained significant (HR 1.87; 95% CI 1.17–2.99)
after controlling for age, sex, race, smoking status,
BMI, diabetes, hypertension, alcohol use, and hy-
perlipidemia [18].
The mechanism behind this association was
initially thought to be through hypertension induced
by hay fever. However, even after controlling for
diagnosed hypertension, this association remained.
Hay fever is associated with the release of inflam-
matory mediators such as histamine, leukotrienes,
prostaglandins and cytokines [18]. Perhaps it is this
heightened systemic inflammation that increases
the risk of stroke. Another possibility could be the
effects of the use of antihistamines. Patients with
hay fever who use antihistamines may be at in-
creased risk of stroke because of severe hay fever
or an iatrogenic response to antihistamines [18].
Judging by this study, a history of hay fever seems
to be a risk factor for stroke. Given the high preva-
lence of hay fever, (10.8% of patients ages 45–64),
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this association may be an area for future research
and investigation [18].
Conclusions
The implications of allergic rhinitis, chronic
bronchitis, and asthma deserve increased focus on
the possibility of co-morbidity for hypertension.
Allergic disease and hypertension are increasingly
prevalent with each year that goes by. Their com-
mon foundation — that of inflammation — and their
demonstrated association prompt the question of
whether controlling atopy would improve BP con-
trol, and vice versa. Another interesting question
posed is whether the chronic inflammation of poor-
ly controlled atopy would increase vulnerability to
cerebrovascular thrombotic events and stroke. Al-
though current data is sparse, it does provide an
intriguing hypothesis and an avenue for future ap-
proach. If hypertension is indeed partly related to
an allergic phenomenon, such an association could
significantly change the clinical management of
hypertension. As clinicians, one possibility is to
screen patients with asthma, sinusitis, or allergic
rhinitis for elevated BP or vice versa.
In addition to the commonality of inflammation
for all of these allergic disorders, another common-
ality may be the use of sympathomimetic agents,
such as nasal decongestants, to relieve allergic
symptoms. These medications are clearly capable
of producing elevated BP. More research needs to
be done to delineate whether allergic disorders are
indeed related to hypertension. Confounders such
as sympathomimetic agents may be playing a role.
In conclusion, there is mounting evidence that
allergic diseases may play a role in the pathogene-
sis of hypertension. Although associations between
allergic diseases and hypertension have been re-
ported, more studies must be performed to eluci-
date the mechanisms behind such associations.
A lot more work needs to be done to prove a causal
relationship. A randomized, prospective trial in
which two normotensive groups — one with and
one without allergies — are compared over time for
incidence of hypertension might be useful. As al-
luded to earlier, the use of vasoconstrictors would
have to be monitored. Ultimately, given the epide-
miological relationship between allergy and hyper-
tension, therapies that target allergic diseases may
also be of benefit in hypertension.
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